Turkish Journal of Geriatrics 2012 , Vol 15, Issue 1
CHRONIC NECROTIZING PULMONARY ASPERGILLOSIS IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA-M2 IN REMISSION
Abdulkadir KÜÇÜKBAYRAK1, Leyla Yılmaz AYDIN2, Yurdanur ERDOĞAN2, Çiğdem BİBEROĞLU2, Derya HOŞGÜN2, Yetkin AGAÇKIRAN3
1Atatürk Göğüs Hastalıkları ve Göğüs Cerrahisi Eğitim ve Araştırma Hastanesi, Enfeksiyon Hastalıkları Ve Klinik Mikrobiyoloji Kliniği ANKARA
2Atatürk Göğüs Hastalıkları ve Göğüs Cerrahisi Eğitim ve Araştırma Hastanesi, Göğüs Hastalıkları Kliniği ANKARA
3Atatürk Göğüs Hastalıkları ve Göğüs Cerrahisi Eğitim ve Araştırma Hastanesi, Patoloji Laboratuvarı ANKARA
This paper presents a case of chronic necrotizing pulmonary aspergillosis (CNPA) in a 61-yearold male patient with acute myeloid leukemia-M2 (AML-M2). The patient was admitted to our clinic with non-productive cough for eight months and hemoptysis for four months. He had been diagnosed with AML-M2 and treated with cytosine-arabinoside and idarubicin seven months earlier. Thorax computed tomography (CT) demonstrated bilateral, perivascular, and multiple small nodules as well as multiple thick wall cavitary lesions with irregular margins in the entire lung areas, especially the upper lobes. An open lung biopsy by thoracotomy was performed and mixed inflammatory cells, necrosis (without caseation), multinuclear giant cells, epitheloid histiocytes, and aspergillus hyphae with bronchial wall destruction were seen in biopsy specimens from the right upper lobe. The patient was treated with amphotericine B for three weeks. As a follow-up, itraconazole was administered for a year. The patient is the first case where CNPA along with an overt immune-compromising disease such as AML-M2 has been observed in one patient. Keywords : Leukemia, Myeloid, Acute; Invasive Pulmonary Aspergillosis; Itraconazole; Thoracotomy